Vivos Therapeutics, Inc. Common Stock (VVOS) is a publicly traded Healthcare sector company. As of July 16, 2026, VVOS trades at $0.43 with a market cap of $5.69M and a P/E ratio of -0.20. VVOS moved +1.39% today. Year to date, VVOS is -79.66%; over the trailing twelve months it is -93.87%. Its 52-week range spans $0.38 to $7.95. Analyst consensus is buy with an average price target of $2.12. Rallies surfaces VVOS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for VVOS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.43 |
| Market Cap | $5.69M |
| P/E Ratio | -0.20 |
| EPS | $-2.14 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.95 |
| 52-Week Low | $0.38 |
| Volume | 56.15K |
| Avg Volume | 0 |
| Revenue (TTM) | $19.57M |
| Net Income | $-25.12M |
| Gross Margin | 61.80% |
3 analysts cover VVOS: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.12.